tiprankstipranks
Enliven Therapeutics, Inc. (ELVN)
NASDAQ:ELVN
US Market
ELVN
Enliven Therapeutics
RESEARCH TOOLSreports
Want to see ELVN full AI Analyst Report?

Enliven Therapeutics (ELVN) Income Statement

333 Followers

Enliven Therapeutics Income Statement

Last quarter (Q1 2026), Enliven Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Enliven Therapeutics's net income was $-23.63M. See Enliven Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -263.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 119.39M$ 104.55M$ 83.53M$ 38.79M$ 24.76M
Depreciation and Amortization
$ 263.00K$ 317.00K$ 297.00K$ 215.00K$ 115.00K
EBITDA
$ -119.39M$ -104.24M$ -83.23M$ -38.58M$ -24.65M
Operating Income
$ -119.66M$ -104.55M$ -83.53M$ -38.79M$ -24.76M
Other Income/Expenses
$ 15.96M$ 15.76M$ 11.95M$ 1.13M$ 22.00K
Pretax Income
$ -103.69M$ -88.79M$ -71.58M$ -37.66M$ -24.74M
Net Income
$ -103.69M$ -89.02M$ -71.58M$ -37.66M$ -24.74M
Per Share Metrics
Basic EPS
$ -1.83$ -1.89$ -2.01$ -6.03$ -3.17
Diluted EPS
$ -1.83$ -1.89$ -2.01$ -6.03$ -3.17
Weighted Average Shares Outstanding
 56.66M 47.07M 35.55M 6.25M 7.81M
Weighted Average Shares Outstanding (Diluted)
 56.66M 47.07M 35.55M 6.25M 7.82M
Currency in USD

Enliven Therapeutics Earnings and Revenue History